Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/8451
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | NASSAR JUNIOR, Antonio Paulo | - |
dc.contributor.author | FARIAS, Alberto Queiroz | - |
dc.contributor.author | ALBUQUERQUE, Luiz Augusto Carneiro d' | - |
dc.contributor.author | CARRILHO, Flair Jose | - |
dc.contributor.author | MALBOUISSON, Luiz Marcelo Sa | - |
dc.date.accessioned | 2015-02-06T19:42:25Z | - |
dc.date.available | 2015-02-06T19:42:25Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | PLOS ONE, v.9, n.9, article ID e107466, 7p, 2014 | - |
dc.identifier.issn | 1932-6203 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/8451 | - |
dc.description.abstract | Background: Hepatorenal syndrome (HRS) is a severe and progressive functional renal failure occurring in patients with cirrhosis and ascites. Terlipressin is recognized as an effective treatment of HRS, but it is expensive and not widely available. Norepinephrine could be an effective alternative. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of norepinephrine compared to terlipressin in the management of HRS. Methods: We searched the Medline, Embase, Scopus, CENTRAL, Lilacs and Scielo databases for randomized trials of norepinephrine and terlipressin in the treatment of HRS up to January 2014. Two reviewers collected data and assessed the outcomes and risk of bias. The primary outcome was the reversal of HRS. Secondary outcomes were mortality, recurrence of HRS and adverse events. Results: Four studies comprising 154 patients were included. All trials were considered to be at overall high risk of bias. There was no difference in the reversal of HRS (RR = 0.97, 95% CI = 0.76 to 1.23), mortality at 30 days (RR = 0.89, 95% CI = 0.68 to 1.17) and recurrence of HRS (RR = 0.72; 95% CI = 0.36 to 1.45) between norepinephrine and terlipressin. Adverse events were less common with norepinephrine (RR = 0.36, 95% CI = 0.15 to 0.83). Conclusions: Norepinephrine seems to be an attractive alternative to terlipressin in the treatment of HRS and is associated with less adverse events. However, these findings are based on data extracted from only four small studies. | - |
dc.language.iso | eng | - |
dc.publisher | PUBLIC LIBRARY SCIENCE | - |
dc.relation.ispartof | Plos One | - |
dc.rights | openAccess | - |
dc.subject.other | controlled-trial | - |
dc.subject.other | cirrhosis | - |
dc.subject.other | noradrenaline | - |
dc.subject.other | pilot | - |
dc.subject.other | albumin | - |
dc.subject.other | predictors | - |
dc.subject.other | diagnosis | - |
dc.subject.other | survival | - |
dc.subject.other | ascites | - |
dc.title | Terlipressin versus Norepinephrine in the Treatment of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis | - |
dc.type | article | - |
dc.rights.holder | Copyright PUBLIC LIBRARY SCIENCE | - |
dc.identifier.doi | 10.1371/journal.pone.0107466 | - |
dc.subject.wos | Multidisciplinary Sciences | - |
dc.type.category | review | - |
dc.type.version | publishedVersion | - |
hcfmusp.description.articlenumber | e107466 | - |
hcfmusp.description.issue | 9 | - |
hcfmusp.description.volume | 9 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | WOS:000342684500103 | - |
hcfmusp.origem.id | 2-s2.0-84925808474 | - |
hcfmusp.publisher.city | SAN FRANCISCO | - |
hcfmusp.publisher.country | USA | - |
hcfmusp.relation.reference | Alessandria C, 2007, J HEPATOL, V47, P499, DOI 10.1016/j.jhep.2007.04.010 | - |
hcfmusp.relation.reference | Angeli P, 2012, J HEPATOL, V57, P1135, DOI 10.1016/j.jhep.2012.06.024 | - |
hcfmusp.relation.reference | Arroyo V, 2011, NAT REV NEPHROL, V7, P517, DOI 10.1038/nrneph.2011.96 | - |
hcfmusp.relation.reference | Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1002/hep.510230122 | - |
hcfmusp.relation.reference | Carvalho Grazielle Cerqueira de, 2012, Ann Hepatol, V11, P90 | - |
hcfmusp.relation.reference | Dobre M, 2011, INT UROL NEPHROL, V43, P175, DOI 10.1007/s11255-010-9725-8 | - |
hcfmusp.relation.reference | Duvoux C, 2002, HEPATOLOGY, V36, P374, DOI 10.1053/jhep.2002.34343 | - |
hcfmusp.relation.reference | Ghosh S, 2013, LIVER INT, V33, P1187, DOI 10.1111/liv.12179 | - |
hcfmusp.relation.reference | GINES A, 1993, GASTROENTEROLOGY, V105, P229 | - |
hcfmusp.relation.reference | Gluud LL, 2012, COCHRANE DB SYST REV, V9, DOI 10.1002/14651858.CD005162.PUB3 | - |
hcfmusp.relation.reference | Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928 | - |
hcfmusp.relation.reference | Hiremath SB, 2013, INDIAN J PHARMACOL, V45, P54, DOI 10.4103/0253-7613.106436 | - |
hcfmusp.relation.reference | Kiszka-Kanowitz M, 2004, SCAND J GASTROENTERO, V39, P486, DOI 10.1080/00365520310008728 | - |
hcfmusp.relation.reference | Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700 | - |
hcfmusp.relation.reference | Martin-Llahi M, 2008, GASTROENTEROLOGY, V134, P1352, DOI 10.1053/j.gastro.2008.02.024 | - |
hcfmusp.relation.reference | Narahara Y, 2009, J GASTROEN HEPATOL, V24, P1791, DOI 10.1111/j.1440-1746.2009.05873.x | - |
hcfmusp.relation.reference | Nazar A, 2010, HEPATOLOGY, V51, P219, DOI 10.1002/hep.23283 | - |
hcfmusp.relation.reference | Salerno F, 2011, J HEPATOL, V55, P1241, DOI 10.1016/j.jhep.2011.03.012 | - |
hcfmusp.relation.reference | Salerno F, 2007, GUT, V56, P1310, DOI 10.1136/gut.2006.107789 | - |
hcfmusp.relation.reference | Sanyal AJ, 2008, GASTROENTEROLOGY, V134, P1360, DOI 10.1053/j.gastro.2008.02.014 | - |
hcfmusp.relation.reference | Sharma P, 2008, AM J GASTROENTEROL, V103, P1689, DOI 10.1111/j.1572-0241.2008.01828.x | - |
hcfmusp.relation.reference | Singh V, 2012, J HEPATOL, V56, P1293, DOI 10.1016/j.jhep.2012.01.012 | - |
hcfmusp.relation.reference | Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80 | - |
dc.description.index | MEDLINE | - |
hcfmusp.citation.scopus | 107 | - |
hcfmusp.scopus.lastupdate | 2024-03-29 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MGT Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/07 Artigos e Materiais de Revistas Científicas - LIM/08 Artigos e Materiais de Revistas Científicas - LIM/37 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_NASSAR JUNIOR_Terlipressin_versus_Norepinephrine_in_the_Treatment_of_Hepatorenal_2014.PDF | publishedVersion (English) | 733.35 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.